Bleomycin - History

History

See also: History of cancer chemotherapy

Bleomycin was first discovered in 1966 when the Japanese scientist Hamao Umezawa found anticancer activity while screening culture filtrates of S. verticullus. Umezawa published his discovery in 1966. The drug was launched in Japan by Nippon Kayaku in 1969. In the US, bleomycin gained FDA approval in July 1973. It was initially marketed in the US by the Bristol-Myers Squibb precursor, Bristol Laboratories, under the brand name Blenoxane.

Read more about this topic:  Bleomycin

Famous quotes containing the word history:

    The history of progress is written in the blood of men and women who have dared to espouse an unpopular cause, as, for instance, the black man’s right to his body, or woman’s right to her soul.
    Emma Goldman (1869–1940)

    America is, therefore the land of the future, where, in the ages that lie before us, the burden of the World’s history shall reveal itself. It is a land of desire for all those who are weary of the historical lumber-room of Old Europe.
    Georg Wilhelm Friedrich Hegel (1770–1831)

    The history of our era is the nauseating and repulsive history of the crucifixion of the procreative body for the glorification of the spirit.
    —D.H. (David Herbert)